title: Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant.
authors.affiliation: Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
authors.forename: Shannon W
authors.initials: SW
authors.lastname: Finks
authors.affiliation: Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
authors.forename: Kelly C
authors.initials: KC
authors.lastname: Rogers
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects*; D000931:Antidotes / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D000069604:Dabigatran / Q000037:antagonists & inhibitors*; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000931:Antidotes; C000594745:idarucizumab; D000069604:Dabigatran